PL101951B1 - A method of producing new ether derivatives of oxime - Google Patents

A method of producing new ether derivatives of oxime Download PDF

Info

Publication number
PL101951B1
PL101951B1 PL1976199557A PL19955776A PL101951B1 PL 101951 B1 PL101951 B1 PL 101951B1 PL 1976199557 A PL1976199557 A PL 1976199557A PL 19955776 A PL19955776 A PL 19955776A PL 101951 B1 PL101951 B1 PL 101951B1
Authority
PL
Poland
Prior art keywords
compounds
oxime
compound
potency
acid
Prior art date
Application number
PL1976199557A
Other languages
English (en)
Polish (pl)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL101951B1 publication Critical patent/PL101951B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/04—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes
    • C07C249/08—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of oximes by reaction of hydroxylamines with carbonyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1976199557A 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime PL101951B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7503310A NL7503310A (nl) 1975-03-20 1975-03-20 Verbindingen met antidepressieve werking.

Publications (1)

Publication Number Publication Date
PL101951B1 true PL101951B1 (pl) 1979-02-28

Family

ID=19823424

Family Applications (3)

Application Number Title Priority Date Filing Date
PL1976199557A PL101951B1 (pl) 1975-03-20 1976-03-17 A method of producing new ether derivatives of oxime
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu

Family Applications After (2)

Application Number Title Priority Date Filing Date
PL1976199556A PL100052B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych eterowych pochodnych oksymu
PL1976188006A PL100614B1 (pl) 1975-03-20 1976-03-17 Sposob wytwarzania nowych,eterowych pochodnych oksymu

Country Status (27)

Country Link
US (1) US4085225A (cg-RX-API-DMAC10.html)
JP (1) JPS6026776B2 (cg-RX-API-DMAC10.html)
AR (2) AR211011A1 (cg-RX-API-DMAC10.html)
AT (1) AT340895B (cg-RX-API-DMAC10.html)
AU (1) AU505358B2 (cg-RX-API-DMAC10.html)
BE (1) BE839744A (cg-RX-API-DMAC10.html)
CA (1) CA1076142A (cg-RX-API-DMAC10.html)
CH (4) CH626057A5 (cg-RX-API-DMAC10.html)
DD (1) DD128332A5 (cg-RX-API-DMAC10.html)
DE (1) DE2610886A1 (cg-RX-API-DMAC10.html)
DK (1) DK144942C (cg-RX-API-DMAC10.html)
ES (1) ES446192A1 (cg-RX-API-DMAC10.html)
FI (1) FI61875C (cg-RX-API-DMAC10.html)
FR (1) FR2304336A1 (cg-RX-API-DMAC10.html)
GB (1) GB1535226A (cg-RX-API-DMAC10.html)
GR (1) GR60052B (cg-RX-API-DMAC10.html)
HU (1) HU171030B (cg-RX-API-DMAC10.html)
IE (1) IE43768B1 (cg-RX-API-DMAC10.html)
IL (1) IL49238A (cg-RX-API-DMAC10.html)
IT (1) IT1063064B (cg-RX-API-DMAC10.html)
MX (1) MX9203723A (cg-RX-API-DMAC10.html)
NL (1) NL7503310A (cg-RX-API-DMAC10.html)
PL (3) PL101951B1 (cg-RX-API-DMAC10.html)
SE (1) SE410312B (cg-RX-API-DMAC10.html)
SU (3) SU635867A3 (cg-RX-API-DMAC10.html)
YU (1) YU39345B (cg-RX-API-DMAC10.html)
ZA (1) ZA761434B (cg-RX-API-DMAC10.html)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1110460B (it) * 1977-03-02 1985-12-23 Ciba Geigy Ag Prodotti che favoriscono la crescita delle piante e prodotti che proteggono le piante a base di eteri di ossime e di esteri di ossime loro preparazione e loro impiego
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
PT759299E (pt) * 1995-08-16 2000-09-29 Lilly Co Eli Potenciacao da resposta de serotonina
IN182588B (cg-RX-API-DMAC10.html) 1998-05-12 1999-05-08 Sun Pharmaceutical Ind Ltd
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
IN186677B (cg-RX-API-DMAC10.html) 1999-11-12 2001-10-20 Sun Pharmaceutical Ind Ltd
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20080021085A1 (en) * 2000-04-13 2008-01-24 Mayo Foundation For Medical Education And Research Method of reducing abeta42 and treating diseases
US7256191B2 (en) * 2000-04-24 2007-08-14 Aryx Therapeutics Materials and methods for the treatment of depression
WO2001080845A2 (en) 2000-04-24 2001-11-01 Aryx Therapeutics (2-aminoethyl) oxime derivatives for the treatment of depression
CN103288815A (zh) * 2001-10-12 2013-09-11 阿泽范药品公司 β-内酰胺后叶加压素V1a拮抗剂
AU2003217676B2 (en) 2002-02-22 2009-06-11 Takeda Pharmaceutical Company Limited Active agent delivery systems and methods for protecting and administering active agents
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
AU2004311577A1 (en) * 2003-07-11 2005-07-21 Myriad Genetics, Inc. Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
WO2005025675A1 (en) 2003-09-12 2005-03-24 Pfizer Limited Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors
DK1689721T3 (da) * 2003-11-26 2010-09-20 Pfizer Prod Inc Aminopyrazolderivater som GSK-3-ihibitorer
DK1691811T3 (da) 2003-12-11 2014-10-20 Sunovion Pharmaceuticals Inc Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2601709C (en) 2005-03-22 2017-02-14 Azevan Pharmaceuticals, Inc. Beta-lactamylalkanoic acids
MX2007012883A (es) 2005-04-22 2007-12-10 Wyeth Corp Derivados de dihidrobenzofurano y usos de los mismos.
AU2006239922A1 (en) 2005-04-22 2006-11-02 Wyeth Benzofuranyl alkanamine derivatives and uses thereof as 5-HT2c agonists
CA2603900A1 (en) * 2005-04-22 2006-11-02 Wyeth Crystal forms of {[(2r)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
BRPI0610037A2 (pt) * 2005-04-22 2010-05-25 Wyeth Corp derivados de dihidrobenzofurano e uso dos mesmos
SG163588A1 (en) * 2005-07-08 2010-08-30 Braincells Inc Methods for identifying agents and conditions that modulate neurogenesis
US20070015832A1 (en) * 2005-07-14 2007-01-18 Myriad Genetics, Incorporated Methods of treating overactive bladder and urinary incontinence
EP1910346B1 (en) * 2005-07-19 2019-02-27 Azevan Pharmaceuticals, Inc. Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist
WO2007014124A2 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
FR2912057B1 (fr) * 2007-02-07 2009-04-17 Sanofi Aventis Sa Composition pharmaceutique contenant en association le saredutant et un inhibiteur selectif de la recapture de la serotonine ou un inhibiteur de la recapture de la serotonine/norepinephrine
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
RU2008135326A (ru) * 2006-03-24 2010-04-27 Вайет (Us) Терапевтические композиции для лечения депрессии
JP4615470B2 (ja) * 2006-03-29 2011-01-19 卓郎 簑和田 大脳の認知力を用いた疾患治療・予防の方法および医薬
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2021000A2 (en) 2006-05-09 2009-02-11 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
TW200817003A (en) * 2006-07-31 2008-04-16 Sanofi Aventis Pharmaceutical composition comprising, in combination, saredutant and a selective serotonin peuptake inhibitor or a serotonin/norepinephrine reuptake inhibitor
MX2009002496A (es) 2006-09-08 2009-07-10 Braincells Inc Combinaciones que contienen un derivado de 4-acilaminopiridina.
WO2008034032A2 (en) * 2006-09-14 2008-03-20 Azevan Pharmaceuticals, Inc. Beta-lactam cannabinoid receptor modulators
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
WO2009128058A1 (en) 2008-04-18 2009-10-22 UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al Psycho-pharmaceuticals
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
RS54945B1 (sr) 2009-10-23 2016-11-30 Janssen Pharmaceutica Nv Disupstituisani oktahidropirolo[3,4-c]piroli kao oreksin receptor modulatori
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ 眼疾患を治療する化合物および方法
EP2587919B1 (en) 2010-07-01 2017-12-13 Azevan Pharmaceuticals, Inc. Methods for treating post traumatic stress disorder
EP2685966A1 (en) 2011-03-17 2014-01-22 Lupin Limited Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor
KR101427221B1 (ko) * 2012-08-29 2014-08-13 주식회사 에스텍파마 플루복사민 자유 염기의 정제방법 및 이를 이용한 고순도 플루복사민 말레이트의 제조방법
IN2013MU01290A (cg-RX-API-DMAC10.html) * 2013-04-03 2015-04-10 Zcl Chemicals Ltd
PL3104847T3 (pl) 2014-02-07 2021-07-05 Támogatott Kutatócsoportok Irodája Nowe zastosowanie związków agonistycznych receptora sigma-1
SG11201608064WA (en) 2014-03-28 2016-10-28 Azevan Pharmaceuticals Inc Compositions and methods for treating neurodegenerative diseases
DK3426251T3 (da) 2016-03-10 2022-06-20 Janssen Pharmaceutica Nv Fremgangsmåder til behandling af depression under anvendelse af orexin-2-receptorantagonister
US12239125B2 (en) 2016-11-24 2025-03-04 SigmaDrugs Kutató Korlátolt Felelsség Társaság Compositions for organ preservation
US11628160B2 (en) 2017-09-15 2023-04-18 Azevan Pharmaceuticals, Inc. Compositions and methods for treating brain injury
CA3145388A1 (en) 2019-07-19 2021-01-28 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens
US11806334B1 (en) 2023-01-12 2023-11-07 Bioxcel Therapeutics, Inc. Non-sedating dexmedetomidine treatment regimens

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes

Also Published As

Publication number Publication date
DE2610886C2 (cg-RX-API-DMAC10.html) 1987-09-24
CA1076142A (en) 1980-04-22
FR2304336A1 (fr) 1976-10-15
JPS51125345A (en) 1976-11-01
IT1063064B (it) 1985-02-11
IE43768B1 (en) 1981-05-20
GB1535226A (en) 1978-12-13
AU1214776A (en) 1977-09-22
FR2304336B1 (cg-RX-API-DMAC10.html) 1979-09-28
SU635867A3 (ru) 1978-11-30
IL49238A (en) 1978-08-31
PL100614B1 (pl) 1978-10-31
PL100052B1 (pl) 1978-08-31
DK144942B (da) 1982-07-12
AU505358B2 (en) 1979-11-15
NL7503310A (nl) 1976-09-22
GR60052B (en) 1978-04-04
IE43768L (en) 1976-09-20
US4085225A (en) 1978-04-18
YU71476A (en) 1982-10-31
SE7603341L (sv) 1976-09-21
AT340895B (de) 1978-01-10
CH629761A5 (de) 1982-05-14
MX9203723A (es) 1992-07-01
ES446192A1 (es) 1977-10-01
CH629184A5 (de) 1982-04-15
DK144942C (da) 1982-12-06
SU645559A3 (ru) 1979-01-30
SE410312B (sv) 1979-10-08
BE839744A (fr) 1976-09-20
JPS6026776B2 (ja) 1985-06-25
AR211153A1 (es) 1977-10-31
FI61875B (fi) 1982-06-30
FI61875C (fi) 1982-10-11
CH629477A5 (de) 1982-04-30
YU39345B (en) 1984-10-31
IL49238A0 (en) 1976-05-31
HU171030B (hu) 1977-10-28
DD128332A5 (de) 1977-11-09
FI760699A7 (cg-RX-API-DMAC10.html) 1976-09-21
DE2610886A1 (de) 1976-10-07
ATA195476A (de) 1977-05-15
CH626057A5 (cg-RX-API-DMAC10.html) 1981-10-30
ZA761434B (en) 1977-10-26
DK115976A (da) 1976-09-21
SU620206A3 (ru) 1978-08-15
AR211011A1 (es) 1977-10-14

Similar Documents

Publication Publication Date Title
PL101951B1 (pl) A method of producing new ether derivatives of oxime
DE69215965T2 (de) Pyrazolopyridinverbindungen und Verfahren zu ihrer Herstellung
DE1695124A1 (de) Verfahren zur Herstellung von Tetrahydroazepinderivaten
JPS6049192B2 (ja) 新規置換ベンズアミド、その製造方法及びこれを有効成分とする向精神薬
DE19638020A1 (de) Die gastrointestinale Durchblutung fördernde Arzneimittel
EP1529041B1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
US4528289A (en) Corynantheine derivates, processes for their preparation, and their use
EP0096279B1 (de) N-(2-Methoxyethyl)-noroxymorphon, dessen Säureadditionssalze, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung
US4065451A (en) 1,3-Dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one, substituted diamino acetate esters and their acid salts
EP0525584A1 (de) 6-Oxo-azepinoindol-Verbindungen sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0025109B1 (de) 1-Benzoxepin-5(2H)-on-Derivate und ihre Salze sowie Verfahren zu deren Herstellung
DE69328701T2 (de) Diazabicycloderivate als 5-HT3-Antagonisten
US4859664A (en) Derivatives of 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonines and -1,4-benzoxazonines, processes for their production and their use as pharmaceuticals
FI61182B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva butylaminderivat
PL101885B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu
PL101949B1 (pl) A method of producing new ether derivatives of oxime
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4013679A (en) Substituted 6,7-dihydro [1,7-ab](1) benzazepine compounds
US4605673A (en) 7H-dibenzo(a,c,)cyclohepten-5-one-(7) derivatives
AU592358B2 (en) Derivatives of diphenoxyethylamine, a process for their production and the pharmaceutical compositions containing the same
DD210266A5 (de) Verfahren zur herstellung von 3-(ureidocyclohexylamino)-propan-1,2-diolderivaten
DE2125892A1 (de) Verfahren zur Herstellung von neuen Thiepinderivaten
US3943254A (en) Beta-adrenergic antagonists
US3646010A (en) Spiroazetidine-ethanoanthracenes
PL100615B1 (pl) Sposob wytwarzania nowych eterowych pochodnych oksymu